The pound’s volatility and its implications What happened to the pound? The pound may have recovered well after its crash on Monday but the heightened volatility isn’t exactly a good sign for the currency itself. The swings are likely to continue today as traders are shouting for more credible policy between the central bank and…
Wake Me Up When September Ends: A Professional, Educated, and Profit-Focused Blog for Intense Readers Overview: Benchmark 10-year yields are off 6-8 basis points in Europe and the United States. The panic seen at the start of the week in the UK has subsided considerably, as sterling recovered to almost where it was a week…
Rapid Urbanization and Market Expansion in Deodorants and Antiperspirants Industry Seoul, Sept. 30, 2022 (GLOBE NEWSWIRE) – The Global Market Report During the forecast period 2022-2032, the deodorants and antiperspirants market is expected to grow at a value of 5.1% CAGR, according to Fact.MR. With rapid urbanization and the increased development of novel products by…
Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference WOBURN, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that Erica Monaco, Chief Executive Officer, will present at the Roth Inaugural Healthcare Opportunities Conference being held at the Yale…
Microservices Architecture Market Projected to Hit USD 21.67 Billion at a 18.6% CAGR by 2030 New York US, Sept. 29, 2022 (GLOBE NEWSWIRE) – According to a comprehensive research report by Market Research Future (MRFR), the microservices architecture market is set to experience significant growth in the coming years. With a projected value of USD…
Sales of Point-of-Care Diagnostic Tests for Ocular Surface Disease Commence at the American Academy of Ophthalmology Annual Meeting Exclusive Partnership for AXIM Biotechnologies, Inc. SAN DIEGO, Sept. 29, 2022 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting ocular surface diseases, announced today that…
Ocugen, Inc. to Present at Chardan’s 6th Annual Genetic Medicines Conference Introduction MALVERN, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer and…
Welcome to the Future of Healthcare! Smart Drug Delivery Systems Revolutionizing Patient Care The connected autoinjectors category is anticipated to expand rapidly as more companies enter the market with connected autoinjectors enhancing patient satisfaction Wilmington, Delaware, United States, Sept. 29, 2022 (GLOBE NEWSWIRE) — Transparency Market Research Inc. – In 2021, the value of global…
